Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac surgery modulates leucocyte subsets and inflammatory mediators.

Immunology letters·2026
Same author

Service Performance Monitoring in Thoracic Surgery: Application of Statistical Process Control to a State-Wide Registry.

ANZ journal of surgery·2026
Same author

Correction: Formative research for a pre-operative psychosocial screening program for cardiac surgical patients: The EMBRACE study, a mixed methods knowledge to action protocol.

PloS one·2026
Same author

Clinical Outcomes of the POPCORN Study: Pharmacodynamics of Pre-Operative PD1 CheckpOint Blockade and Receptor Activator of NF-κB Ligand (RANKL) Inhibition in Non-Small Cell Lung Cancer (NSCLC)-A Phase 1B/2 Trial.

Asia-Pacific journal of clinical oncology·2026
Same author

Formative research for a pre-operative psychosocial screening program for cardiac surgical patients: The EMBRACE study, a mixed methods knowledge to action protocol.

PloS one·2025
Same author

Pulmonary Complications After Cardiac Surgical Procedures: A Tertiary Centre Audit of Elective and Urgent Cases.

Annals of thoracic surgery short reports·2025

Related Experiment Video

Updated: Jul 16, 2026

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy
04:38

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy

Published on: April 19, 2024

Active pulmonary tuberculosis: experience with resection in 106 cases.

Rishendran Naidoo1

  • 1Department of Cardiothoracic Surgery, Inkosi Albert Luthuli Central Hospital, Mayville, South Africa. rishendran@mweb.co.za

Asian Cardiovascular & Thoracic Annals
|March 28, 2007
PubMed
Summary

Surgical resection for active pulmonary tuberculosis is a viable option, demonstrating acceptable patient outcomes. This study highlights low mortality and manageable morbidity in patients undergoing surgery for complex tuberculosis cases.

More Related Videos

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Related Experiment Videos

Last Updated: Jul 16, 2026

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy
04:38

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy

Published on: April 19, 2024

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Area of Science:

  • Thoracic Surgery
  • Infectious Diseases
  • Pulmonary Medicine

Background:

  • Surgical management of pulmonary tuberculosis has shifted from historical collapse therapies.
  • Resection for active tuberculosis remains a procedure approached with caution.
  • Understanding outcomes of surgical intervention in active pulmonary tuberculosis is crucial.

Purpose of the Study:

  • To retrospectively analyze the outcomes of surgical management for active pulmonary tuberculosis.
  • To evaluate morbidity and mortality rates associated with pulmonary tuberculosis resection.
  • To identify key indications and patient factors influencing surgical outcomes in tuberculosis.

Main Methods:

  • Retrospective review of 106 patients with pathologically proven active pulmonary tuberculosis undergoing surgery (January 1997 - January 2005).
  • Analysis of demographic data, radiographic findings, surgical indications, sputum status, and preoperative drug therapy.
  • Correlation of these factors with postoperative outcomes, including mortality and morbidity.

Main Results:

  • Indications for surgery included multidrug-resistant tuberculosis (27), hemoptysis (44), bronchiectasis (27), and diagnostic uncertainty (8).
  • Two patients (1.9%) experienced postoperative mortality.
  • Overall morbidity was 16.9%, with complications such as postpneumonectomy empyema (6) and bronchopleural fistula (1).

Conclusions:

  • Surgical resection for active pulmonary tuberculosis can be performed with acceptable morbidity and mortality rates.
  • Antituberculous therapy is essential during the perioperative period for patients undergoing surgery.
  • Careful patient selection and management are key to successful surgical outcomes in active tuberculosis.